Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Featured Article
Sas Maheswaran discusses how artificial intelligence, data and strategic partnerships can make clinical trials more sustainable...
Source: ONdrugDelivery
- Featured Article
Andrew Cooper, CEO, CluePoints, explores how AI is transforming clinical trials, the power of a purpose-driven...
Source: European Medical Journal GOLD
- Press Release
RBQM and AI leader was shortlisted for its Time Similarity Test in the ‘Innovative Clinical Trial...
- Featured Article
The monitoring of key risk indicators (KRIs) is an established form of risk control in the...
Source: Applied Clinical Trials
- Press Release
King of Prussia, PA – April 1st, 2025: CluePoints, provider of leading statistical and AI-driven software...
- Featured Article
Richard Young, Chief Strategy Officer at CluePoints, shares insights on AI and risk-based quality management (RBQM)...
Source: The Clinical Trial Vanguard
- Press Release
The Company, along with its Research and Development Teams, were shortlisted for continuing its mission of...
- Featured Article
The pharmaceutical industry is poised for a transformative evolution by 2025, driven by the possibilities of...
Source: PM360
- Featured Article
Central monitoring is highly effective in detecting emerging quality issues in clinical trials, but debate continues...
Source: Applied Clinical Trials
- Featured Article
An essential component of risk-based quality management (RBQM), as detailed in both the ICH E8 (R1)...
Source: Applied Clinical Trials
- Press Release
CluePoints Appoints Richard Young as Chief Strategy Officer King of Prussia, PA – October 28th, 2024:...
- Press Release
King of Prussia, PA – October 23rd, 2024: CluePoints, provider of leading statistical and AI-driven software...
- Press Release
Join us at #CQOF2021! As well as hosting a booth at the Clinical Quality Oversight Forum...
- Press Release
Researchers have been slow to fully adopt innovations designed to overcome the challenges to modern day...
- Press Release
CluePoints, the premier provider of Risk-Based Quality Management software for clinical trials, has partnered with ZS,...
- Press Release
For well over a year now, the clinical research community has been hard at work to...
- Press Release
Risk-Based Monitoring is the future of clinical trials – but despite significant advances in recent years,...
- Press Release
Have you heard the news? CluePoints is sponsoring RBQM Live on behalf of the industry! The...
- Press Release
In the world of clinical trials, if it isn’t documented, it didn’t happen. It’s a philosophy...
- Press Release
It has never been more important for the clinical trial community to come together and share...
- Press Release
King of Prussia, PA – January 19, 2021: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
King of Prussia, PA – December 8th, 2020: CluePoints, the premier provider of Central Statistical Monitoring,...
- Press Release
LOUVAIN-LA-NEUVE, BELGIUM; KING OF PRUSSIA, PA; and LONDON, UK (September 1, 2020) – CluePoints S.A., a...
- Press Release
Addressing COVID-19 Specific Regulatory Guidance and Ensuring Early Risk Detection King of Prussia, PA: CluePoints, the...
- Featured Article
The ICH E6(R3) draft guideline document, currently open to public consultation, places the industry firmly in...
Source: Applied Clinical Trials
- Featured Article
Despite the push for greater use of risk-based quality management (RBQM) in clinical research, adoption of...
Source: CenterWatch
- Featured Article
Central monitoring aims to detect emerging quality-related risks proactively during a clinical trial, resulting in study...
Source: Applied Clinical Trials
- Featured Article
Using key risk indicators (KRIs) can improve clinical trial data quality in 80% of the sites...
Source: Applied Clinical Trials
- Featured Article
Since the release of ICH E6(R2), multiple efforts have been made to interpret the requirements and...
- Read
Source: Springer Link
- Featured Article
An expectation for the use of quality tolerance limits (QTLs) was formally established in the International...
Source: Applied Clinical Trials
- Featured Article
Clinical research is evolving rapidly, with the digitalization of trials creating a new modus operandi and...
Source: Applied Clinical Trials
- Featured Article
Risk-based approaches to monitoring clinical trials were brought to the forefront with an FDA guidance published...
Source: Applied Clinical Trials
- Featured Article
Key risk indicators (KRIs) are metrics designed to identify risks of specific interest to study teams...
Source: Applied Clinical Trials
- Featured Article
The success of clinical development programmes, drug approval and marketing depends ultimately on the readability and...
Source: International Clinical Trials
- Featured Article
Central monitoring, which typically includes the use of key risk indicators (KRIs), aims at improving the...
Source: Springer Link
- Featured Article
Clinical research is in the grips of a revolution that has caused a wave of new...
Source: ACRP
